価格表
在庫・価格 : 2024年05月01日 05時07分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
DKK-1, Human, ELISA Kit (12x8tests) データシート |
BI-20413 |
BMCバイオメディカ BIOMEDICA Medizinprodukte GmbH |
1 kit | ¥156,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年05月01日 05時07分 現在
使用文献
- No.: 1
-
文献情報:
Rossini M et al. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis. Calcif. Tissue Int. 2015 May;96(5):410-6
Rossini M et al
2015/01/01
-
備考:
-
参照:
- No.: 2
-
文献情報:
Kerschan-Schindl K et al. Rheumatoid arthritis in remission : Decreased myostatin and increased serum levels of periostin. Wien. Klin. Wochenschr. 2019 Jan;131(1-2):1-7
Kerschan-Schindl K et al
2019/01/01
-
備考:
-
参照:
- No.: 3
-
文献情報:
Bojanić K et al. Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy. J Clin Med 2018 Sep;7(9)
Bojanić K et al
2018/01/01
-
備考:
-
参照:
- No.: 4
-
文献情報:
Tsourdi E et al. Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment. Bone 2019 Mar;120:44-49
Tsourdi E et al
2019/01/01
-
備考:
-
参照:
- No.: 5
-
文献情報:
Liakou CG et al. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study. Endocrine 2016 Nov;54(2):543-551
Liakou CG et al
2016/01/01
-
備考:
-
参照:
- No.: 6
-
文献情報:
Voskaridou E et al. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density. Horm. Metab. Res. 2012 Nov;44(12):909-13
Voskaridou E et al
2012/01/01
-
備考:
-
参照:
- No.: 7
-
文献情報:
Aufderklamm S et al. Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone Metastases. Dis. Markers 2018;2018:1874598
Aufderklamm S et al
2018/01/01
-
備考:
-
参照:
- No.: 8
-
文献情報:
Wheater G et al. Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. PLoS ONE 2018;13(8):e0201527
Wheater G et al
2018/01/01
-
備考:
-
参照:
- No.: 9
-
文献情報:
Terpos E et al. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. Clin. Exp. Rheumatol. ;29(6):921-5
Terpos E et al
-
備考:
-
参照:
- No.: 10
-
文献情報:
Polyzos SA et al. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide. Osteoporos Int 2012 Mar;23(3):1171-6
Polyzos SA et al
2012/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. BMC Musculoskelet Disord 2012 Oct;13:191
Taylan A et al
2012/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Kerschan-Schindl K et al. Myostatin and other musculoskeletal markers in lung transplant recipients. Clin. Exp. Med. 2019 Feb;19(1):77-85
Kerschan-Schindl K et al
2019/01/01
-
備考:
-
参照:
- No.: 13
-
文献情報:
Mantovani A et al. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab. 2019 09;45(4):347-355
Mantovani A et al
2019/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Sun W et al. Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis. Clin. Rheumatol. 2019 Apr;38(4):989-995
Sun W et al
2019/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Zobel EH et al. Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes. Diabetes Care 2017 03;40(3):e32-e33
Zobel EH et al
2017/01/01
-
備考:
-
参照:
- No.: 16
-
文献情報:
Chang YC et al. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients. BMC Cardiovasc Disord 2018 11;18(1):214
Chang YC et al
2018/01/01
-
備考:
-
参照:
- No.: 17
-
文献情報:
Maruotti N et al. Systemic effects of Wnt signaling. J. Cell. Physiol. 2013 Jul;228(7):1428-32
Maruotti N et al
2013/01/01
-
備考:
-
参照:
- No.: 18
-
文献情報:
Szulc P et al. Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: the STRAMBO study. J. Clin. Endocrinol. Metab. 2014 Feb;99(2):617-24
Szulc P et al
2014/01/01
-
備考:
-
参照:
- No.: 19
-
文献情報:
Terpos E et al. Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates. Am. J. Hematol. 20
Terpos E et al
2019/01/01
-
備考:
-
参照:
- No.: 20
-
文献情報:
Fassio A et al. Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators. Int. Immunopharmacol. 2019 Feb;67:487-489
Fassio A et al
2019/01/01
-
備考:
-
参照:
- No.: 21
-
文献情報:
Yang HY et al. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study. Diab Vasc Dis Res 2019 05;16(3):281-288
Yang HY et al
2019/01/01
-
備考:
-
参照:
- No.: 22
-
文献情報:
Valassi E et al. Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly. Endocr Connect 2019 Jan;8(1):39-49
Valassi E et al
2019/01/01
-
備考:
-
参照:
- No.: 23
-
文献情報:
Terpos E et al. Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma. Int. J. Cancer 2019 Jul;145(2):559-568
Terpos E et al
2019/01/01
-
備考:
-
参照:
- No.: 24
-
文献情報:
Fassio A et al. Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis. Clin. Exp. Rheumatol. ;37(1):133-136
Fassio A et al
-
備考:
-
参照: